NCT05067608 - Study on the Safety and Efficacy of Cryopreserved Platelets in Hypoproliferative Thrombocytopenic Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 25, 2019

Primary Completion Date

March 24, 2021

Study Completion Date

March 24, 2021

Conditions

Hypoproliferative Thrombocytopenia

Interventions

BIOLOGICAL

Control arm receiving normal (never before frozen) platelets as per current clinical practice

Liquid platelets arm (control) and may receive multiple platelet transfusions per thrombocytopenic cycle.

BIOLOGICAL

Treatment arm receiving cryopreserved platelets

Cryopreserved platelets arm (treatment) and may receive multiple platelet transfusions per thrombocytopenic cycle.

Trial Locations (1)

Singapore General Hospital, Singapore